Sugi Predict

Sugi Predict / Compounds / SCHEMBL3948833

SCHEMBL3948833

SCHEMBL3948833

CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](OC(=O)CC(=O)O)CC[C@]4(C)[C@H]3CC[C@]12C

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLA1 P09884 1/20 0.79
▸ CYP46A1 Q9Y6A2 2/20 0.72
▸ USP2 O75604 2/20 0.68
▸ LMNA P02545 1/20 0.68
▸ ABCB1 P08183 1/20 0.68
▸ OSBP P22059 1/20 0.68
▸ RORC P51449 1/20 0.68
▸ OSBP2 Q969R2 1/20 0.68
▸ NPC1 O15118 1/20 0.61
▸ NR1H3 Q13133 3/20 0.61
▸ EPHA2 P29317 1/20 0.61
▸ CYP1A2 P05177 1/20 0.61
▸ PLA2G2A P14555 1/20 0.60
▸ NPC1L1 Q9UHC9 2/20 0.59
▸ FNTA P49354 1/20 0.58
▸ FNTB P49356 1/20 0.58
▸ GRIN1 Q05586 1/20 0.58
▸ GRIN2A Q12879 1/20 0.58
▸ GBA1 P04062 1/20 0.58
▸ UGCG Q16739 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25352571 1.00 POLA1 (0.79) POLA1CYP46A1USP2LMNAABCB1
SCHEMBL27319615 1.00 POLA1 (0.79) POLA1CYP46A1USP2LMNAABCB1
SCHEMBL11522746 1.00 POLA1 (0.79) POLA1CYP46A1USP2LMNAABCB1
SCHEMBL3948835 1.00 POLA1 (0.79) POLA1CYP46A1USP2LMNAABCB1
SCHEMBL3948836 0.96 POLA1 (0.77) POLA1CYP46A1USP2LMNAABCB1
SCHEMBL4123393 0.93 POLA1 (0.73) POLA1CYP46A1USP2LMNAABCB1
SCHEMBL28673756 0.93 POLA1 (0.73) POLA1CYP46A1USP2LMNAABCB1
SCHEMBL1621116 0.93 POLA1 (0.73) POLA1CYP46A1USP2LMNAABCB1
SCHEMBL5329970 0.93 POLA1 (0.73) POLA1CYP46A1USP2LMNAABCB1
SCHEMBL5329971 0.93 POLA1 (0.73) POLA1CYP46A1USP2LMNAABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260109732-A1 LIPID AMINES MODERNATX INC (US) 2026-04-23 — — US disclosed
US-20250235531-A1 MUCOSAL ADMINISTRATION METHODS AND FORMULATIONS MODERNATX, INC. (US) 2025-07-24 — — US disclosed
CN-119604312-A Lipid compositions for in vivo delivery 生命技术公司 2025-03-11 — — CN disclosed
EP-4475882-A1 MUCOSAL ADMINISTRATION METHODS AND FORMULATIONS ModernaTX, Inc. (US) 2024-12-18 — — EP disclosed
EP-4423107-A1 LIPID AMINES ModernaTX, Inc. (US) 2024-09-04 — — EP disclosed
WO-2023154818-A1 MUCOSAL ADMINISTRATION METHODS AND FORMULATIONS MODERNATX, INC. (US) 2023-08-17 — — WO disclosed
WO-2023154818-A1 MUCOSAL ADMINISTRATION METHODS AND FORMULATIONS MODERNATX, INC. (US) 2023-08-17 — — WO disclosed
WO-2023076598-A1 LIPID AMINES MODERNATX, INC. (US) 2023-05-04 — — WO disclosed
WO-2023076598-A1 LIPID AMINES MODERNATX, INC. (US) 2023-05-04 — — WO disclosed
CN-108779074-A Plant virus movement protein and its application method 分子传递有限公司 2018-11-09 — — CN disclosed
EP-1670838-A4 AMPHIPHILIC BLOCK COPOLYMER AND POLYMERIC COMPOSITION COMPRISING THE SAME FOR DRUG DELIVERY SAMYANG CORP (KR) 2009-07-08 — — EP disclosed
CN-100471886-C Amphiphilic block copolymer and polymeric composition comprising the same for drug delivery SAMYANG CORP (KR) 2009-03-25 — — CN disclosed
US-20080152616-A1 Amphiphilic block copolymer and polymeric compostition comprising the same for drug delivery SAMYANG HOLDINGS CORPORATION (KR) 2008-06-26 — — US disclosed
US-7311901-B2 Amphiphilic block copolymer and polymeric composition comprising the same for drug delivery SAMYANG CORPORATION (KR) 2007-12-25 — — US disclosed
EP-1670838-A1 AMPHIPHILIC BLOCK COPOLYMER AND POLYMERIC COMPOSITION COMPRISING THE SAME FOR DRUG DELIVERY Samyang Corporation (KR) 2006-06-21 — — EP disclosed
CN-1780865-A Amphiphilic block copolymer and polymeric composition comprising the same for drug delivery SAMYANG CORP (KR) 2006-05-31 — — CN disclosed
US-20050201972-A1 Amphiphilic block copolymer and polymeric composition comprising the same for drug delivery SAMYANG CORPORATION 2005-09-15 — — US disclosed
WO-2005035606-A1 AMPHIPHILIC BLOCK COPOLYMER AND POLYMERIC COMPOSITION COMPRISING THE SAME FOR DRUG DELIVERY SAMYANG CORPORATION (KR) 2005-04-21 — — WO disclosed
US-4175074-A Serum-soluble cholesterol compounds and method for their preparation MONOBIND, INC., A CORP. OF CA. 1979-11-20 — — US disclosed
US-4040784-A Method for checking the accuracy of a test, using a serum-soluble cholesterol compound MONOBIND, INC., A CORP. OF CA. 1977-08-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080152616-A1 Amphiphilic block copolymer and polymeric compostition comprising the same for drug delivery CETP, ABCB4, TPRKB POLA1 2142/4885CYP46A1 22/4885USP2 1543/4885
US-20250235531-A1 MUCOSAL ADMINISTRATION METHODS AND FORMULATIONS MUC1, RNMT, FABP2 POLA1 1481/4885CYP46A1 1475/4885USP2 1671/4885
US-20050201972-A1 Amphiphilic block copolymer and polymeric composition comprising the same for drug delivery TTPA, CETP, CHKB POLA1 2927/4885CYP46A1 110/4885USP2 1332/4885
US-20260109732-A1 LIPID AMINES LDLR, NPC1, PHOSPHO1 POLA1 2294/4885CYP46A1 156/4885USP2 3959/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback